N@N

KBR, IPE, AMJ, SIVR, OMER, PDM Are Seasonally Ripe To Go Up In the Next Five Weeks

September 23, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of KBR Inc. (NYSE:KBR), SPDR Barclays Capital TIPS ETF (NYSE:IPE), JPMorgan Alerian MLP Index ETN (NYSE:AMJ), ETFS Silver Trust (NYSE:SIVR), Omeros Corporation (NASDAQ:OMER), Piedmont Office Realty Trust (NYSE:PDM) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

The following stocks are expected to go Up:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  KBR     KBR Inc.                         8.01%            88.89% (8 of 9)      Monday, October 17th 2016
  IPE     SPDR Barclays Capital TIPS ETF   0.64%            88.89% (8 of 9)      Monday, October 3rd 2016
  AMJ     JPMorgan Alerian MLP Index ETN   4.47%            85.71% (6 of 7)      Friday, October 21st 2016
  SIVR    ETFS Silver Trust                5.23%            85.71% (6 of 7)      Wednesday, October 5th 2016
  OMER    Omeros Corporation               9.00%            100.00% (6 of 6)     Monday, October 17th 2016
  PDM     Piedmont Office Realty Trust     6.36%            100.00% (6 of 6)     Monday, October 31st 2016

KBR Inc. (NYSE:KBR) - KBR, Inc. operates as an engineering, construction, and services company worldwide. The company operates through three segments: Technology and Consulting, Engineering and Construction, and Government Services. The Technology and Consulting segment offers services and solutions, including licensing, engineering and design, proprietary equipment, plant automation, remote monitoring, catalysts, and related consulting services to hydrocarbons, petrochemicals, chemicals, and fertilizer markets. This segment provides field development planning, technology selection and capital spending optimization, plant integrity management, specialized naval architecture technology, floating production units, and structural engineering; and feasibility studies, revamp studies, planning/development and construction studies. The Engineering and Construction segment provides engineering services, as well as engineering, procurement, and construction project delivery for the development, construction, and commissioning of projects in the oil and gas industries, and liquefied natural gas/gas-to-liquids markets, as well as refining, petrochemicals, chemicals, and fertilizers industries. This segment provides offshore oil and gas services focused on the hydrocarbons value chain from subsea umbilicals, risers, and flowlines to fixed and floating platforms, including hulls, moorings, and risers; and onshore oil and gas services across the hydrocarbons industry. The Government Services segment offers construction, refurbishment, operations, and maintenance of housing, and associated facilities for military personnel to home base, as well as operations support, embassy and critical infrastructure support, life-support programs, heavy equipment transportation, and non-military government facilities management and integration. KBR, Inc. was founded in 1901 and is headquartered in Houston, Texas..

SPDR Barclays Capital TIPS ETF (NYSE:IPE) - SPDR Barclays Capital TIPS ETF.

JPMorgan Alerian MLP Index ETN (NYSE:AMJ) - The Bear Stearns Companies, LLC operates as an investment banking, securities and derivatives trading, and clearance and brokerage company. It operates through Capital Markets, Global Clearing Services, and Wealth Management segments. The Capital Markets segment comprises equities, fixed income, and investment banking operations. Fixed income operations include participating in the auction of, and maintaining proprietary positions in, U.S. treasury bills, notes, bonds, and stripped principal and coupon securities; purchase and origination of commercial and residential mortgage loans; dealing in tax-exempt and taxable municipal securities and instruments; offering hedging and arbitrage services; and trading, making markets, and taking proprietary positions in both dollar and non-dollar investment-grade and non-investment-grade corporate debt securities, commercial loans, sovereign and agency securities. The investment banking operations comprise the provision of services in capital raising, strategic advice, mergers and acquisitions, and merchant banking. The Global Clearing Services segment provides trade execution, securities clearing, custody, financing, securities lending, and technology solutions to hedge funds, broker-dealers, registered investment advisors, and high-net-worth individuals. The Wealth Management segment offers private client services including provision of high-net-worth individuals with an institutional level of transactional, wealth management, and advisory services; and asset management services across various asset classes, including money markets, fixed income, currencies, and equities. The company was founded in 1923 and is headquartered in New York, New York. As of May 30, 2008, The Bear Stearns Companies, LLC operates as a subsidiary of JPMorgan Chase & Co..

ETFS Silver Trust (NYSE:SIVR) - The investment seeks to replicate, net of expenses, the price of silver bullion. The shares are backed by physical allocated silver bullion held by the custodian. All physical silver held conforms to the London Bullion Market Association's rules for good delivery..

Omeros Corporation (NASDAQ:OMER) - Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. It markets OMIDRIA for use during cataract surgery or intraocular lens replacement. The company s clinical products include OMS721 that is in Phase III clinical trials for the treatment of atypical hemolytic uremic syndrome; and in Phase II clinical trials for the treatment of thrombotic microangiopathies, IgA nephropathy, and other renal diseases. Its clinical programs also comprise OMS824, which is in Phase II clinical trials for the treatment of schizophrenia and Huntington's diseases; OMS405 that is in Phase II clinical trials for the treatment of opioid and nicotine addiction; and OMS201, which is in Phase I/II clinical trials for use during urological procedures. The company s preclinical programs include OMS527 for the treatment of addiction and compulsive disorders, as well as for movement disorders, such as Parkinson's disease; OMS616 to control surgical and traumatic bleeding; and OMS906 for the treatment of paroxysmal nocturnal hemoglobinuria and other alternative pathway disorders. Its preclinical programs also comprise GPR17 for the treatment of demyelinating disorders; GPR101 for appetite and eating disorders; GPR151 for the treatment of neuropathic pain and cognition; GPR161 for triple-negative breast cancer treatment; GPR174 for dysfunction of regulatory T-cell modulation; GPR183 for the treatment of osteoporosis and EBV-related diseases; and GPCR and Antibody Platform for CNS, metabolic, CV, oncologic, musculoskeletal, and other disorders. In addition, the company is developing OMS103 that has completed Phase III clinical trials for arthroscopic anterior cruciate ligament reconstruction and arthroscopic partial meniscectomy. Omeros Corporation was incorporated in 1994 and is based in Seattle, Washington..

Piedmont Office Realty Trust (NYSE:PDM) - Piedmont Office Realty Trust, Inc. engages in the acquisition and ownership of commercial real estate properties in the United States. Its property portfolio primarily consists of office and industrial buildings, warehouses, and manufacturing facilities. As of December 31, 2007, the company owned interests in 83 properties that are wholly owned and controlled through consolidated joint ventures. It has elected to be taxed as a real estate investment trust and would not be subject to federal income tax, if it distributes approximately 90% of its taxable income to its shareholders. The company was incorporated in 1997 and is headquartered in Norcross, Georgia..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net